Also trades as: PRM.L (LSE) · $vol 0M
PMSNF OTC
Proteome Sciences plc
1W: +0.0%
1M: +0.0%
3M: -50.0%
YTD: -75.0%
1Y: -80.0%
3Y: -99.1%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.9M
52W Range0.01-0.05
Volume4,000
Avg Volume1,116
Beta0.15
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAnil Wadhwani
Employees32
SectorHealthcare
IndustryMedical - Specialties
IPO Date2010-02-22
Websiteproteomics.com
Coveham House
Cobham, SU KT11 3EP
GB
Cobham, SU KT11 3EP
GB
44 20 7043 2116
About Proteome Sciences plc
Proteome Sciences Plc is a provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Cobham, the United Kingdom.
Latest News
Proteome Sciences (LON:PRM) Shares Up 16.3% – Here’s What Happened
Proteome Sciences (LON:PRM) Shares Cross Below 200-Day Moving Average – Here’s What Happened
Proteome Sciences (LON:PRM) Share Price Crosses Below 200-Day Moving Average – What’s Next?
Proteome Sciences (LON:PRM) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell?
Proteome Sciences (LON:PRM) Stock Price Passes Below 200 Day Moving Average – What’s Next?
Recent Insider Trades
No insider trades found